Multifaceted Factors Causing Conflicting Outcomes in Herb-Drug Interactions

Area of Science:

• Pharmacology
• Pharmacokinetics
• Herbal Medicine Interactions

Background:

• Herb-drug interactions (HDIs) are a significant concern, primarily involving metabolic enzyme and/or transporter-mediated pharmacokinetic (PK) changes in drugs.
• These PK alterations can lead to unpredictable changes in drug efficacy and toxicity, complicating the use of herbal products with conventional medications.

Purpose of the Study:

• To review the underlying mechanisms of PK-based HDIs.
• To summarize key challenges in the study design and interpretation of HDI evaluations, focusing on factors like dose and treatment duration.

Main Methods:

• Review of existing literature on herb-drug interactions.
• Analysis of pharmacokinetic mechanisms involved in HDIs.
• Identification of challenges in preclinical and clinical study designs for HDIs.

Main Results:

• PK-based HDIs are driven by alterations in drug-metabolizing enzymes and transporters.
• Discrepancies persist between predictive preclinical data and clinical significance of HDIs.
• Conflicting reports on HDIs create confusion regarding combined use of herbal products and drugs.

Conclusions:

• Understanding PK mechanisms is essential for predicting and managing HDIs.
• Addressing challenges such as dose-dependency and treatment period effects in study designs is critical for accurate HDI evaluation.
• Improved study designs are needed to clarify the clinical significance of HDIs and ensure patient safety.